Bio-Works Technologies AB BIOWKS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- SEK 3.00
- Day Range
- SEK 2.91–3.01
- 52-Week Range
- SEK 2.76–18.95
- Bid/Ask
- SEK 2.92 / SEK 3.00
- Market Cap
- SEK 116.94 Mil
- Volume/Avg
- 42,347 / 35,538
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.27
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Bio-Works Technologies AB is a Sweden-based life science company which is engaged in designing, developing, manufacturing and supplying products for purification and separation of proteins and other molecules. The product line of the company includes activated resin, immobilized metal-ion affinity chromatography resin, ion exchange chromatography resin, size exclusion chromatography resin and others. The company has also developed affinity chromatography technique, BabyBio Columns, OptiBio glass columns for separating proteins, and protein purification. Bio-Works serves various end users such as academic research laboratories, biopharmaceutical companies, the food and beverage industry and others.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 34
- Website
- https://www.bio-works.com
Comparables
Valuation
|
Metric
|
BIOWKS
|
BICO
|
MCAP
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 38.75 |
Price/Book Value | 2.44 | 0.69 | 5.97 |
Price/Sales | 2.27 | 1.55 | 3.86 |
Price/Cash Flow | — | — | 20.61 |
Price/Earnings
BIOWKS
BICO
MCAP
Financial Strength
|
Metric
|
BIOWKS
|
BICO
|
MCAP
|
|---|---|---|---|
Quick Ratio | 2.68 | 1.76 | 1.35 |
Current Ratio | 3.29 | 2.41 | 2.23 |
Interest Coverage | −18,537.67 | −16.51 | 14.80 |
Quick Ratio
BIOWKS
BICO
MCAP
Profitability
|
Metric
|
BIOWKS
|
BICO
|
MCAP
|
|---|---|---|---|
Return on Assets (Normalized) | −42.22% | −4.22% | 10.75% |
Return on Equity (Normalized) | −49.87% | −6.38% | 17.72% |
Return on Invested Capital (Normalized) | −50.16% | −4.08% | 13.91% |
Return on Assets
BIOWKS
BICO
MCAP
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Ymkfktykn | Fmgx | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Fyqdycy | Wmyjj | $103.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Xrzqbxb | Hhpnq | $97.8 Bil | |
MRNA
| Moderna Inc | Fqnqxlq | Ybmj | $38.8 Bil | |
ARGX
| argenx SE ADR | Jnwslfkp | Nxbp | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Srjywqlr | Dqf | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Tnvrtzwk | Gzndp | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Zppdcgcf | Vltjnl | $17.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Jbxdqxtjs | Lbszyvc | $12.5 Bil | |
INCY
| Incyte Corp | Qfxbghq | Swtvgh | $11.5 Bil |